Comparative effectiveness of antibiotics for uncomplicated urinary tract infections: Network meta-analysis of randomized trials

Family Practice

Volumn 29, Issue 6, 2012, Pages 659-670

  Knottnerus, Bart J ^a   Grigoryan, Larissa ^b,c   Geerlings, Suzanne E ^a   Moll van charante, Eric P ^a   Verheij, Theo J M ^b   Kessels, Alphons G H ^d   Ter riet, Gerben ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anti infective agents; Meta analysis; Primary health care; Urinary tract infections

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CIPROFLOXACIN; COTRIMOXAZOLE; FOSFOMYCIN; GATIFLOXACIN; NITROFURANTOIN; NORFLOXACIN; PEFLOXACIN; PIVMECILLINAM; PLACEBO; PRULIFLOXACIN; SULFAMETHIZOLE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL DECISION MAKING; COMPARATIVE EFFECTIVENESS; DRUG EFFICACY; FOLLOW UP; GENERAL PRACTICE; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; OUTPATIENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINGLE DRUG DOSE; UNSPECIFIED SIDE EFFECT; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; COMPARATIVE EFFECTIVENESS RESEARCH; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY ASSURANCE, HEALTH CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 84870034619     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cms029     Document Type: Article

References (54)

1. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002; 113 (Suppl 1A): 5S-13S.
2. Grabe M, Bjerklund-Johansen TE, Botto H et al. EAU Guidelines on Urological infections, update March 2011. Arnhem, The Netherlands: EAU Guidelines Office, 2011.
3. Nicolle L. Best pharmacological practice: urinary tract infections. Expert Opin Pharmacother 2003; 4: 693-704.
4. Warren JW,Abrutyn E,Hebel JR et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 1999; 29: 745-58.
5. Zalmanovici TA, Green H, Paul M, Yaphe J, Leibovici L. Antimicrobial agents for treating uncomplicated urinary tract infection in women. Cochrane Database of Systemic Reviews 2010 issue 10. Art. No.: CD007182.
6. Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated communityacquired urinary tract infections.Ann Intern Med 2001; 135: 41-50.
7. Hooton TM, Besser R, Foxman B, Fritsche TR, Nicolle LE. Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy. Clin Infect Dis 2004; 39: 75-80.
8. Falagas ME, Kotsantis IK, Vouloumanou EK, Rafailidis PI. Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials. J Infec 2009; 58: 91-102.
9. Caldwell DM, Ades AE, Higgins JP. Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ 2005; 331 (7521): 897-900.
10. Glenny AM, Altman DG, Song F et al. Indirect comparisons of competing interventions. Health Technol Assess 2005; 9 (26): 1-148.
11. Bucher HC, Guyatt GH, Griffith LE, Walter SD. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol 1997; 50 (6): 683-91.
12. Hasselblad V. Meta-analysis of multitreatment studies. Med Decis Making 1998; 18: 37-43.
13. Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 2004; 23: 3105-24.
14. Lumley T. Network meta-analysis for indirect treatment comparisons. Stat Med 2002; 21: 2313-24.
15. Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother 2003; 51(1): 69-76.
16. Naber KG, Schito G, Botto H, Palou J, Mazzei T. Surveillance study in Europe and Brazil on clinical aspects and antimicrobial resistance Epidemiology in females with cystitis (ARESC): implications for empiric therapy. Eur Urol 2008; 54: 1164-75.
17. Zhanel GG, Hisanaga TL, Laing NM et al. Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American urinary tract infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents 2006; 27: 468-75.
18. Higgins JPT, Green S. (eds). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org. (accessed on 13 April 2012).
19. Boutron I, Moher D, Tugwell P. A checklist to evaluate a report of a nonpharmacological trial (CLEAR NPT) was developed using consensus. J Clin Epidemiol 2005; 58: 1233-40.
20. van Tulder M, Furlan A, Bombardier C, Bouter L. Updated method guidelines for systematic reviews in the cochrane collaboration back review group. Spine (Phila Pa 1976) 2003; 28: 1290-9.
21. Arredondo-Garci{dotless}́a JL, Figueroa DR, Rosas A et al. Comparison of short-term treatment regimen of ciprofloxacin versus longterm treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study. J Antimicrob Chemother 2004; 54: 840-3.
22. Bjerrum L, Gahrn-Hansen B, Grinsted P. Pivmecillinam versus sulfamethizole for short-term treatment of uncomplicated acute cystitis in general practice: a randomized controlled trial. Scand J Prim Health Care 2009; 27: 6-11.
23. Cervigni M, Orticelli G, Bologna M et al. Single-dose prulifloxacin versus single-dose pefloxacin in the treatment of acute uncomplicated urinary tract infection in women. Urogynaecol Int J 2003; 17: 69-77.
24. Christiaens TCM, De Meyere M, Verschraegen G et al. Randomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult women. Br J Gen Pract 2002; 52: 729-34.
25. Ferry SA, Holm SE, Stenlund H, Lundholm R, Monsen TJ. Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: the LUTIW project. Scand J Prim Health Care 2007; 25: 49-57.
26. Gupta K, Hooton TM, Roberts PL, Stamm WE. Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women. Arch Intern Med 2007; 167: 2207-12.
27. Hooton TM, Scholes D, Gupta K et al. Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial. JAMA 2005; 293: 949-55.
28. Naber KG, Allin DM, Clarysse L et al. Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections. Int J Antimicrob Agents 2004; 23: 596-605.
29. Nicolle LE, Madsen KS, Debeeck GO et al. Three days of pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women. Scand J Infect Dis 2002; 34: 487-92.
30. Park J, Min K, Kang D. The efficacy and safety of a once-daily extended-release ciprofloxacin tablet for the empirical treatment of symptomatic uncomplicated cystitis in Korean women. [Korean]. Korean J Urol 2007; 48: 35-9.
31. Richard GA, Mathew CP, Kirstein JM, Orchard D, Yang JY. Single-dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women: results from a randomized, double-blind, multicenter trial comparing single-dose to 3-day fluoroquinolone regimens. Urology 2002; 59: 334-9.
32. van Pienbroek E, Hermans J, Kaptein AA, Mulder JD. Fosfomycin trometamol in a single dose versus seven days nitrofurantoin in the treatment of acute uncomplicated urinary tract infections in women. Pharm World Sci 1993; 15: 257-62.
33. Davey SG, Egger M, Phillips AN. Meta-analysis. Beyond the grand mean? BMJ 1997; 315: 1610-4.
34. Gupta K, Hooton TM, Naber KG et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011; 52: e103-20.
35. Nicolle LE. Pivmecillinam in the treatment of urinary tract infections. J Antimicrob Chemother 2000; 46 (Suppl 1): 35-9.
36. Sutton AJ, Higgins JP. Recent developments in meta-analysis. Stat Med 2008; 27: 625-50.
37. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
38. Karlowsky JA, Kelly LJ, Thornsberry C et al. Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking resistance in the United States Today. The Surveillance network. Int J Antimicrob Agents 2002; 19: 21-31.
39. Schito GC, Naber KG, Botto H et al. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents 2009; 34: 407-13.
40. Stewart LA, Parmar MK. Meta-analysis of the literature or of individual patient data: is there a difference? Lancet 1993; 341: 418-22.
41. Katchman EA, Milo G, Paul M et al. Three-day vs longer duration of antibiotic treatment for cystitis in women: systematic review and meta-analysis. Am J Med 2005; 118: 1196-207.
42. Lutters M, Vogt N. Antibiotic duration for treating uncomplicated, symptomatic lower urinary tract infections in elderly women. Cochrane Database of Systemic Reviews 2002, issue 3. Art. No.: CD001535.
43. Milo G, Katchman EA, Paul M et al. Duration of antibacterial treatment for uncomplicated urinary tract infection in women. Cochrane Database of Systemic Reviews 2005, issue 2. Art. No.: CD004682.
44. Rafalsky V, Andreeva I, Rjabkova E. Quinolones for uncomplicated acute cystitis in women. Cochrane Database of Systematic Reviews 2006, issue 3. Art. No.: CD003597.
45. McGauran N, Wieseler B, Kreis J et al. Reporting bias in medical research-a narrative review. Trials 2010; 11: 37.
46. Song F, Harvey I, Lilford R. Adjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventions. J Clin Epidemiol 2008; 61: 455-63.
47. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
48. Lu GB, Ades AE. Assessing evidence inconsistency in mixed treatment comparisons. J Am Stat Assoc 2006; 101: 447-59.
49. Song F, Xiong T, Parekh-Bhurke S et al. Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study. BMJ 2011; 343: d4909.
50. Higgins J, Thompson S, Deeks J, Altman D. Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. J Health Serv Res Policy 2002; 7: 51-61.
51. Salanti G, Higgins JP, Ades AE, Ioannidis JP. Evaluation of networks of randomized trials. Stat Methods Med Res 2008; 17: 279-301.
52. Thompson SG. Why sources of heterogeneity in meta-analysis should be investigated. BMJ 1994; 309: 1351-5.
53. Deeks JJ. Issues in the selection of a summary statistic for metaanalysis of clinical trials with binary outcomes. Stat Med 2002; 21: 1575-600.
54. Engels EA, Schmid CH, Terrin N, Olkin I, Lau J. Heterogeneity and statistical significance in meta-analysis: an empirical study of 125 meta-analyses. Stat Med 2000; 19: 1707-28.